
The episode explores the complexities of pharmaceutical commercialization with guest Anish Shindore, focusing on incentives and real-world patient access.
Send us Fan Mail A medicine can be proven safe and effective, approved by regulators, and still fail the one test that matters: actually reaching patients in the real world. We sit down with Anish, a deep commercial thinker, to unpack what pharmaceutical commercialisation really is when you strip away the slogans and look at incentives, bottlenecks, and human behaviour. We start with our five value streams model of the pharmaceutical industry and use it to explore a provocative idea: m...
Explore listener stats, chart rankings, contacts and more on the Lab to Lives podcast page.